Volume 9, Issue 2 | Heart Failure Reviews

Search all Heart Failure Reviews articles

Volume 9, Issue 2

April 2004

Special Issue: An Overview of Beta-Blockers and Heart Failure

Issue Editor:

Syed M. Jafri

10 articles in this issue

Editorial
Syed M. Jafri
Editorial Introduction Pages: 89 - 89
Biologic Rationale for the Use of Beta-Blockers in the Treatment of Heart Failure
Hani N. Sabbah
OriginalPaper Pages: 91 - 97
B-Type Natriuretic Peptide and the Right Heart
Lok Bin Yap
OriginalPaper Pages: 99 - 105
Beta Blocker Therapy After Acute Myocardial Infarction in Patients with Heart Failure and Systolic Dysfunction
Emil Thattassery
Mihai Gheorghiade
OriginalPaper Pages: 107 - 113
The Effects of Beta Blockers on Morbidity and Mortality in Heart Failure
Syed M. Jafri
OriginalPaper Pages: 115 - 121
Beta-Blockers in Heart Failure: Are Pharmacological Differences Clinically Important?
Marco Metra
Livio Dei Cas
Philip Poole-Wilson
OriginalPaper Pages: 123 - 130
Pharmacokinetics and Pharmacodynamics of Beta Blockers in Heart Failure
Robert L. Talbert
OriginalPaper Pages: 131 - 137
Beta Blockers as Anti-Arrhythmic Agents
Daejoon Anh
Joseph E. Marine
OriginalPaper Pages: 139 - 147
Sex-Related Differences in Heart Failure and Beta-Blockers
Jalal K. Ghali
OriginalPaper Pages: 149 - 159
Beta Blocker Therapy in African American Patients with Heart Failure
Sidney Goldstein
OriginalPaper Pages: 161 - 167